000 | 01272 a2200337 4500 | ||
---|---|---|---|
005 | 20250518000405.0 | ||
264 | 0 | _c20200610 | |
008 | 202006s 0 0 eng d | ||
022 | _a1477-0377 | ||
024 | 7 |
_a10.1177/1358863X18796936 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBonaca, Marc P | |
245 | 0 | 0 |
_aPolyvascular disease and risk: When two is not better than one. _h[electronic resource] |
260 |
_bVascular medicine (London, England) _c12 2018 |
||
300 |
_a531-533 p. _bdigital |
||
500 | _aPublication Type: Editorial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
650 | 0 | 4 |
_aCerebrovascular Disorders _xcomplications |
650 | 0 | 4 |
_aCoronary Artery Disease _xcomplications |
650 | 0 | 4 |
_aFibrinolytic Agents _xclassification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 |
_aPeripheral Arterial Disease _xcomplications |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSecondary Prevention _xmethods |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aThrombosis _xetiology |
773 | 0 |
_tVascular medicine (London, England) _gvol. 23 _gno. 6 _gp. 531-533 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1358863X18796936 _zAvailable from publisher's website |
999 |
_c28852800 _d28852800 |